Abstract:Recently, fatty acid binding proteins 5 and 7 (FABP5 and FABP7) have been regarded as the prospective targets for clinically treating multiple diseases related to FABPs. In this work, multiple short molecular dynamics (MSMD) simulations followed by binding free energy calculations were performed to investigate the binding selectivity of three inhibitors, namely, 65X, 8KS, and 5M8 toward FABP5 and FABP7. The RMSF analysis suggests that the structural flexibility of FABP5 is stronger than that of FABP7; moreover, the calculated molecular surface area of FABP5 is also larger than that of FABP7. Meanwhile, the results from the cross-correlation analysis show that the inhibitor bindings exert different impacts on the internal dynamics of FABP5 and FABP7. Binding free energies predicted by the molecular mechanics/generalized Born surface area (MM-GBSA) method indicate that the increase in the enthalpy changes caused by the bindings of inhibitors toward FABP7 relative to FABP5 mostly drives the binding selectivity of the inhibitors toward FABP5 versus FABP7. Hierarchical clustering analysis based on the energy contributions of separate residues and calculations of residue-based free energy decompositions were carried out by using the equilibrated MSMD trajectories. The obtained results not only recognize the hot interaction spots of inhibitors with FABP5 and FABP7, but also display that several common residues, namely, (T56, T54), (L60, F58), (E75, E73), (A76, A78), (D79, D77), (R81, R79), (R107, R109), (C120, L118), and (R129, R127) belonging to (FABP5, FABP7) induce obvious binding differences in the inhibitors toward FABP5 and FABP7. Therefore, these residues play significant roles in the binding selectivities of inhibitors toward FABP5 and FABP7.

Design, Synthesis and Biological Evaluation of FABP4/5 Inhibitors Based on Quinoline Scaffold

Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists

Identification of New Dual FABP4/5 Inhibitors Based on a Naphthalene-1-sulfonamide FABP4 Inhibitor.

Structural Insights into Ligand Binding Features of Dual FABP4/5 Inhibitors by Molecular Dynamics Simulations

Design, synthesis, and biological evaluation of novel highly selective non-carboxylic acid FABP1 inhibitors

Optimization of Potent, Selective and Orally Bioavailable Biphenyl Scaffold As FABP4 Inhibitors for Anti-Inflammation.

Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.

From Hit to Lead: Structure-based Discovery of Naphthalene-1-sulfonamide Derivatives As Potent and Selective Inhibitors of Fatty Acid Binding Protein 4.

Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists.

Analysis of binding affinity and docking of novel fatty acid-binding protein (FABP) ligands

Development of FABP4/5 inhibitors with potential therapeutic effect on type 2 Diabetes Mellitus

Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z Toward Fatty Acid Binding Proteins 4 and 5.

ChemInform Abstract: Design, Synthesis and Biological Activity Evaluation of 2,5‐diphenyl‐1,3,4‐oxadiazole Derivatives As Novel Inhibitors of Fructose‐1,6‐bisphosphatase.

Pyrazolidine-3,5-dione Derivatives As Potent Non-Steroidal Agonists of Farnesoid X Receptor: Virtual Screening, Synthesis, and Biological Evaluation.

Design, Synthesis and Molecular Docking of 1,3,4-Oxadiazole-2(3H)-thione Derivatives Containing 1,4-Benzodioxane Skeleton as Potential FabH Inhibitors

Design, Synthesis, and Biological Evaluation of First-in-class FABP1 Inhibitors for the Treatment of NASH

Discovery of novel fructose-1,6-bisphosphatase inhibitors bearing benzimidazole scaffold using a dual-ligand molecular docking model

Molecular Mechanism with Regard to the Binding Selectivity of Inhibitors Toward FABP5 and FABP7 Explored by Multiple Short Molecular Dynamics Simulations and Free Energy Analyses

Structure-based design of free fatty acid receptor 1 agonists bearing non-biphenyl scaffold

Design and Synthesis of Novel Deoxybenzoin Derivatives As FabH Inhibitors and Anti-Inflammatory Agents

Lipid Accumulation Inhibitory Activities of Novel Isoxazole-Based Chenodeoxycholic Acids: Design, Synthesis and Preliminary Mechanism Study